These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34686459)

  • 21. Augmented Renal Clearance in Critically Ill Patients: A Systematic Review.
    Bilbao-Meseguer I; Rodríguez-Gascón A; Barrasa H; Isla A; Solinís MÁ
    Clin Pharmacokinet; 2018 Sep; 57(9):1107-1121. PubMed ID: 29441476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmented renal clearance in the critically ill: how to assess kidney function.
    Grootaert V; Willems L; Debaveye Y; Meyfroidt G; Spriet I
    Ann Pharmacother; 2012; 46(7-8):952-9. PubMed ID: 22693271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Initial dose of vancomycin based on body weight and creatinine clearance to minimize inadequate trough levels in Japanese adults.
    Maki N; Ohkuchi A; Tashiro Y; Kim MR; Le M; Sakamoto T; Matsubara S; Hakamata Y
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2537-43. PubMed ID: 22391760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of glomerular filtration rate using iohexol plasma clearance in critically ill patients with augmented renal creatinine clearance: A single-centre retrospective study.
    Collet M; Hijazi D; Sevrain P; Barthélémy R; Labeyrie MA; Prié D; Tabibzadeh N; Mebazaa A; Chousterman BG
    Eur J Anaesthesiol; 2021 Jun; 38(6):652-658. PubMed ID: 33742973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetic model of Vancomycin based on therapeutic drug monitoring data in critically ill septic patients.
    Kovacevic T; Miljkovic B; Kovacevic P; Dragic S; Momcicevic D; Avram S; Jovanovic M; Vucicevic K
    J Crit Care; 2020 Feb; 55():116-121. PubMed ID: 31715528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical verification of vancomycin population pharmacokinetics in patients with augmented renal clearance].
    Lu H; Tang L; Xue S; Zhuang Z; Fang J; Zhao F; Shang E
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 May; 30(5):444-448. PubMed ID: 29764549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment].
    Campassi ML; Gonzalez MC; Masevicius FD; Vazquez AR; Moseinco M; Navarro NC; Previgliano L; Rubatto NP; Benites MH; Estenssoro E; Dubin A
    Rev Bras Ter Intensiva; 2014; 26(1):13-20. PubMed ID: 24770684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Outcomes of Protocolized Antibiotic Dosing in Critically Ill Surgical Patients With Bacteremia and Augmented Renal Clearance Compared With Critically Ill Surgical Patients Without Augmented Renal Clearance.
    Gordon M; Lantz E; Mentzer C; Hall A
    Surg Infect (Larchmt); 2024 Mar; 25(2):155-159. PubMed ID: 38335446
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury--true GFR versus urinary creatinine clearance and estimating equations.
    Bragadottir G; Redfors B; Ricksten SE
    Crit Care; 2013 Jun; 17(3):R108. PubMed ID: 23767877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between hemoglobin levels and vancomycin clearance in patients with sepsis.
    Chuma M; Makishima M; Imai T; Tochikura N; Suzuki S; Kuwana T; Sawada N; Iwabuchi S; Sekimoto M; Nakayama T; Sakaue T; Kikuchi N; Yoshida Y; Kinoshita K
    Eur J Clin Pharmacol; 2019 Jul; 75(7):929-937. PubMed ID: 30868193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Augmented Renal Clearance on Vancomycin Pharmacokinetics and Pharmacodynamics in Critically Ill Patients.
    Tesfamariam NS; Aboelezz A; Mahmoud SH
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmented renal clearance--an evolving risk factor to consider during the treatment with vancomycin.
    Minkutė R; Briedis V; Steponavičiūtė R; Vitkauskienė A; Mačiulaitis R
    J Clin Pharm Ther; 2013 Dec; 38(6):462-7. PubMed ID: 23924288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing Aminoglycoside Dosing Regimens for Critically Ill Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches.
    Avedissian SN; Rohani R; Bradley J; Le J; Rhodes NJ
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function.
    Ishii H; Hirai K; Sugiyama K; Nakatani E; Kimura M; Itoh K
    Ther Drug Monit; 2018 Dec; 40(6):693-698. PubMed ID: 30157096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance.
    Nicolau DP; De Waele J; Kuti JL; Caro L; Larson KB; Yu B; Gadzicki E; Zeng Z; Rhee EG; Rizk ML
    Int J Antimicrob Agents; 2021 Apr; 57(4):106299. PubMed ID: 33567333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Index for the appropriate vancomycin dosing in premature neonates and infants.
    Endo A; Nemoto A; Hanawa K; Ishikawa T; Koshiishi M; Maebayashi Y; Hasebe Y; Naito A; Kobayashi Y; Isobe K; Kawano Y; Hanawa T
    Pediatr Int; 2022 Jan; 64(1):e14905. PubMed ID: 34197665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
    Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
    J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
    Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment implications of augmented renal clearance in a critically ill COVID-19 patient: A case report.
    Deenen S; Fransen LFC; Jaspers TCC; Workum JD
    Fundam Clin Pharmacol; 2023 Oct; 37(5):1011-1015. PubMed ID: 37161707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommended Antibiotic Dosage Regimens in Critically Ill Patients with Augmented Renal Clearance: A Systematic Review.
    Silva CM; Baptista JP; Santos I; Martins P
    Int J Antimicrob Agents; 2022 May; 59(5):106569. PubMed ID: 35288259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.